Group 1 - The core point of the news is that Shouyao Holdings has seen a 5% increase in stock price, reaching 41.13 CNY per share, with a total market capitalization of 6.117 billion CNY [1] - Shouyao Holdings, established on April 19, 2016, specializes in the research and development of small molecule anti-tumor drugs, with 100% of its revenue coming from technology development and services [1] - The trading volume for Shouyao Holdings was 43.6067 million CNY, with a turnover rate of 1.68% [1] Group 2 - From the perspective of fund holdings, Guotai Fund has a significant position in Shouyao Holdings, with its Guotai Innovation Medical Mixed Fund A holding 26,200 shares, accounting for 4.77% of the fund's net value [2] - The Guotai Innovation Medical Mixed Fund A, established on April 18, 2023, has a current scale of 17.7778 million CNY and has achieved a year-to-date return of 45.74% [2] - The fund manager, Qiu Xiaoxu, has a tenure of 3 years and 78 days, with the fund's total assets amounting to 676 million CNY [2]

Core Viewpoint - The article provides a ranking of open-end mutual funds based on their net asset value growth as of August 6, 2025, highlighting the top and bottom performers in the market [2][4][6]. Group 1: Top Performing Funds - The top 10 funds with the highest net value growth include: 1. Zhonghai Charm Yangtze River Delta Mixed Fund (3.1350) 2. Hengyue Smart Technology Mixed C Fund (1.1892) 3. Hengyue Smart Technology Mixed A Fund (1.1996) 4. Minsheng Jianyin Frontier Technology Mixed Fund (1.0201) 5. Tongtai Competitive Advantage Mixed A Fund (1.1032) 6. Tongtai Competitive Advantage Mixed C Fund (1.0802) 7. Furong Fuxin Mixed C Fund (2.1194) 8. Furong Fuxin Mixed A Fund (2.1560) 9. Hongyi Yuanfang Selected Mixed C Fund (1.1215) 10. Hongyi Yuanfang Selected Mixed A Fund (1.1231) [2][4]. Group 2: Bottom Performing Funds - The bottom 10 funds with the lowest net value growth include: 1. Guotai Innovation Medical Mixed Initiation C Fund (1.1799) 2. Guotai Innovation Medical Mixed Initiation A Fund (1.1901) 3. Wanjia Pharmaceutical Quantitative Stock Selection Mixed Initiation C Fund (1.2070) 4. Wanjia Pharmaceutical Quantitative Stock Selection Mixed Initiation A Fund (1.2165) 5. Morgan Stanley Youyue Anhe Mixed C Fund (0.6632) 6. Morgan Stanley Youyue Anhe Mixed A Fund (0.6727) 7. Hongde Medical Innovation Mixed Initiation A Fund (1.0426) 8. Hongde Medical Innovation Mixed Initiation C Fund (1.0274) 9. Guotai Growth Enterprise Board Medical Health ETF (1.2310) 10. Tianhong Medical Innovation A Fund (1.0690) [4][6]. Group 3: Market Overview - The Shanghai Composite Index showed a slight upward trend, with a trading volume of 1.75 trillion, and the number of advancing stocks was 3,357 compared to 1,817 declining stocks [6]. - Leading sectors included shipbuilding and general machinery, both rising over 3%, while the tourism sector experienced declines [6].